Skip to content
  • Home
  • CoursesExpand
    • B.Pharm Old Syllabus Notes (Archive)Expand
      • SEM-I oldExpand
        • Human Anatomy and Physiology-IExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical AnalysisExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutics – 1Expand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Inorganic ChemistryExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Remedial BiologyExpand
          • Unit 1
          • rb Unit 2
      • SEM-IIExpand
        • Human Anatomy and Physiology – IIExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • BiochemistryExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • PathophysiologyExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Organic Chemistry IExpand
          • poc1 Unit 1
      • SEM-IIIExpand
        • Pharmaceutical Organic Chemistr IIExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Physical Pharmaceutics IExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical MicrobiologyExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical EngineeringExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Universal human values and professional ethicsExpand
          • value Unit 1
      • SEM-IVExpand
        • Pharmaceutical Organic Chemistry IIIExpand
          • POC 3 Unit 1
          • POC 3 Unit 2
        • Medicinal Chemistry – IExpand
          • Unit 1
        • Physical Pharmaceutics – IIExpand
          • Unit 1
          • pp2 Unit 2
        • Pharmacology-1Expand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmacognosy and Phytochemistry – IExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
      • SEM-VExpand
        • Medicinal Chemistry IIExpand
          • mc2 Unit 1
        • Industrial Pharmacy IExpand
          • Unit 1
          • Unit 2
          • BIP Unit 3
          • BIP Unit 4
        • Pharmacology-IIExpand
          • Unit 1
          • Unit 2
          • colo2 Unit 3
        • Pharmacognosy & Phytochemistry IIExpand
          • Unit 1
          • Unit 2
          • cog Unit 3
        • Pharmaceutical JurisprudenceExpand
          • Unit 1
          • Unit 2
          • Unit 3
          • juris Unit 4
      • SEM-VIExpand
        • Medicinal Chemistry IIIExpand
          • MC III Unit 1
        • Herbal Drug TechnologyExpand
          • Unit 1
          • HDT Unit 2
        • Biopharmaceutics & PharmacokineticsExpand
          • kinet Unit 1
          • Kinet Unit 2
        • Pharmaceutical BiotechnologyExpand
          • Unit 1
          • Unit 2
          • biotech Unit 3
        • Pharmaceutical Quality AssuranceExpand
          • Unit 1
      • SEM- VIIExpand
        • Instrumental Method of AnalysisExpand
          • lysis Unit 1
          • Unit 3
          • Unit 4
          • Unit 5
        • Industrial Pharmacy-IIExpand
          • IP 2 Unit 1
        • Pharmacy PracticeExpand
          • Unit 1
          • pp Unit 2
        • Novel Drug Delivery SystemExpand
          • Unit 1
          • ndds Unit 2
      • SEM-VIIIExpand
        • Biostatistics and Research MethodologyExpand
          • Unit 1
        • PharmacovigilanceExpand
          • Unit-1
          • Unit 2
          • Unit 3
          • vigi Unit 4
        • Social and Preventive PharmacyExpand
          • Social Unit 1
    • B.Pharm New PCI Syllabus 2026Expand
      • SEM-1 newExpand
        • Basics of Python Programming for Pharmaceutical SciencesExpand
          • Unit 1
          • Python Unit 2
        • General PharmacyExpand
          • Unit 1
          • Unit 2
          • Unit 3
        • Healthcare Psychology and Communication SkillsExpand
          • Unit 1
          • HPCS Unit 2
        • Human Anatomy, Physiology and Pathophysiology IExpand
          • Unit 1
          • New HAP Unit 2
        • Introduction to PharmacognosyExpand
          • Unit 1
        • Pharmaceutical Inorganic and Analytical ChemistryExpand
          • Unit 1
          • Unit 2
          • new ana Unit 3
    • D.PharmaExpand
      • PharmaceuticsExpand
        • Chapter 1
        • Chapter 2
        • Chpater 3
        • Chpater 4
        • dceu Chapter 5
      • Pharmaceutical ChemistryExpand
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • dchem Chapter 6
      • PharmacognosyExpand
        • Chapter 3
        • Chapter 1
        • Chapter 2
        • Chapter 4
        • cogno Chapter 5
      • Human Anatomy and PhysiologyExpand
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • Chapter 6
        • Chapter 7
        • Chapter 8
        • Chapter 9
        • Chapter 10
        • Chapter 11
        • Chapter 12
        • Chapter 13
        • Chapter 14
        • Chapter 15
      • Social PharmacyExpand
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • sp Chapter 4
      • PharmacologyExpand
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • Chapter 6
        • Chapter 7
        • Chapter 8
        • Chapter 9
        • Chapter 10
        • Chapter 11
        • Chapter 12
        • Chapter 13
      • Community pharmacy and managementExpand
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 5
        • Chapter 6
        • Chapter 7
        • cpm Chapter 8
      • Biochemistry & Clinical PathologyExpand
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • Chapter 6
        • Chapter 7
      • PharmacotherapeuticsExpand
        • Chapter 1
        • the Chapter 2
      • Hospital and Clinical PharmacyExpand
        • Chapter 1
        • Chapter 2
        • hcp Chapter 3
      • Pharmacy law and EthicsExpand
        • Chapter 1
        • Chapter 2
    • M.PharmExpand
      • Pharmacology Branch
    • Pharm DExpand
      • Human Anatomy & Physiology (D)Expand
        • Unit 1
        • Unit 2
        • Unit 3
        • hap Unit 4 (D)
        • Unit 5
        • Unit 6
        • Unit 7
        • Unit 8
        • Unit 9
        • Unit 10
        • Unit 11
        • Unit 12
        • hap Unit 13
    • DMLTExpand
      • dmlt 1 yearExpand
        • Anatomy and Physiology
  • Study MaterialExpand
    • Practicals
    • Notes pdf
    • Previous year papers
    • Books
  • Blog
  • Jobs
  • Syllabus
  • pH, Buffers, and Isotonic Solutions
    Home | Unit 5

    pH, Buffers, and Isotonic Solutions

    ByDeepak Rajput March 3, 2024March 16, 2025

    pH (Potential of Hydrogen) pH is a measure of the acidity or alkalinity of a solution. It quantifies the concentration of hydrogen ions (H+) in a solution. The pH scale ranges from 0 to 14, with 7 being neutral. Values below 7 indicate acidity, and values above 7 indicate alkalinity. Mathematical Expression: pH = -log[H+]…

    Read More pH, Buffers, and Isotonic SolutionsContinue

  • Thermodynamic treatment of stability constants
    Home | Unit 4

    Thermodynamic treatment of stability constants

    ByDeepak Rajput March 2, 2024March 2, 2024

    The thermodynamic treatment of stability constants involves the use of thermodynamic principles to describe the formation and stability of complexes in solution. Stability constants, also known as formation constants or equilibrium constants, quantify the extent to which a complex is formed from its constituent species. Here’s a detailed note on the thermodynamic treatment of stability…

    Read More Thermodynamic treatment of stability constantsContinue

  • Crystalline structures of complexes
    Home | Unit 4

    Crystalline structures of complexes

    ByDeepak Rajput March 2, 2024February 26, 2025

    The crystalline structures of complexes refer to the three-dimensional arrangements of atoms and molecules in a crystal lattice, specifically those involving coordination compounds or complexes. Coordination compounds are entities formed by the coordination of ligands to a central metal atom or ion. These compounds often exhibit unique and interesting structural features, making studying their crystalline…

    Read More Crystalline structures of complexesContinue

  • Protein Binding Analysis
    Home | Unit 4

    Protein Binding Analysis

    ByDeepak Rajput March 2, 2024July 15, 2025

    Protein Binding Analysis: Analyzing protein binding, complexation, and drug action is crucial to pharmaceutical research and development. Understanding the interactions between drugs and their target proteins provides insights into drug efficacy, safety, and potential side effects. Below is a detailed note on various methods employed to analyze protein binding, complexation, and drug action: Protein Binding…

    Read More Protein Binding AnalysisContinue

  • Complexation: Introduction, Classification, and Applications
    Home | Unit 4

    Complexation: Introduction, Classification, and Applications

    ByDeepak Rajput March 2, 2024March 2, 2024

    Introduction to Complexation Complexation, a fundamental chemical phenomenon, involves the formation of complexes between a central metal atom or ion and surrounding ligands. This process creates coordination compounds, wherein the metal entity interacts with multiple ligands through coordinate bonds. The study of complexation is crucial in various scientific disciplines, including chemistry, biochemistry, and materials science….

    Read More Complexation: Introduction, Classification, and ApplicationsContinue

  • Viral Infections – SARS-CoV-2 (COVID-19): Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management
    Home | the Chapter 2

    Viral Infections – SARS-CoV-2 (COVID-19): Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management

    ByDeepak Rajput February 27, 2024February 27, 2024

    SARS-CoV-2 is a novel coronavirus responsible for the coronavirus disease 2019 (COVID-19). It was first identified in Wuhan, China, in late 2019 and has since led to a global pandemic. Etiopathogenesis 1. Transmission: Primarily spreads through respiratory droplets when an infected person coughs, sneezes, or talks. 2. Viral Entry: SARS-CoV-2 enters human cells via the…

    Read More Viral Infections – SARS-CoV-2 (COVID-19): Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological managementContinue

  • Opportunistic Infections: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management
    Home | the Chapter 2

    Opportunistic Infections: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management

    ByDeepak Rajput February 26, 2024February 26, 2024

    Opportunistic infections (OIs) are infections caused by pathogens that typically do not cause disease in individuals with intact immune systems but can exploit weakened immunity, as seen in conditions such as HIV/AIDS, immunosuppressive therapies, or certain medical conditions. Opportunistic infections can affect various organs and systems, leading to severe and potentially life-threatening complications. Etiopathogenesis 1….

    Read More Opportunistic Infections: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological managementContinue

  • HIV (Human Immunodeficiency Virus): Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management
    Home | the Chapter 2

    HIV (Human Immunodeficiency Virus): Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management

    ByDeepak Rajput February 26, 2024February 26, 2024

    HIV is a retrovirus that attacks the immune system, specifically the CD4 cells (T cells), which play a crucial role in the body’s defense mechanism. The virus can lead to the progressive failure of the immune system and, if untreated, can result in acquired immunodeficiency syndrome (AIDS). Etiopathogenesis 1. Transmission: HIV is primarily transmitted through…

    Read More HIV (Human Immunodeficiency Virus): Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological managementContinue

  • Syphilis: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management
    Home | the Chapter 2

    Syphilis: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological management

    ByDeepak Rajput February 26, 2024February 26, 2024

    Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. It progresses through distinct stages, each characterized by specific clinical manifestations. If left untreated, syphilis can lead to severe complications, affecting various organs and systems. Etiopathogenesis 1. Transmission:    – Mainly transmitted through sexual contact (vaginal, anal, or oral) with an infected…

    Read More Syphilis: Definition, etiopathogenesis, clinical manifestations, non-pharmacological and pharmacological managementContinue

  • Gonorrhea: Definition, Etiopathogenesis, Clinical Manifestations.
    Home | the Chapter 2

    Gonorrhea: Definition, Etiopathogenesis, Clinical Manifestations.

    ByDeepak Rajput February 26, 2024December 13, 2025

    Gonorrhea Gonorrhea is a highly prevalent sexually transmitted infection (STI) caused by the pathogenic bacterium Neisseria gonorrhoeae. It represents one of the most significant bacterial STIs globally and remains a major challenge to public health systems due to its high transmission rate, frequent asymptomatic nature, severe reproductive complications, and the alarming emergence of multidrug-resistant strains….

    Read More Gonorrhea: Definition, Etiopathogenesis, Clinical Manifestations.Continue

Page navigation

Previous PagePrevious 1 … 110 111 112 113 114 … 212 Next PageNext
  • About Pharmaacademias
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

© 2026 - WordPress Theme by Kadence WP

  • Home
  • Courses
    • B.Pharm Old Syllabus Notes (Archive)
      • SEM-I old
        • Human Anatomy and Physiology-I
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Analysis
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutics – 1
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Inorganic Chemistry
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Remedial Biology
          • Unit 1
          • rb Unit 2
      • SEM-II
        • Human Anatomy and Physiology – II
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Biochemistry
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pathophysiology
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Organic Chemistry I
          • poc1 Unit 1
      • SEM-III
        • Pharmaceutical Organic Chemistr II
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Physical Pharmaceutics I
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Microbiology
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmaceutical Engineering
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Universal human values and professional ethics
          • value Unit 1
      • SEM-IV
        • Pharmaceutical Organic Chemistry III
          • POC 3 Unit 1
          • POC 3 Unit 2
        • Medicinal Chemistry – I
          • Unit 1
        • Physical Pharmaceutics – II
          • Unit 1
          • pp2 Unit 2
        • Pharmacology-1
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
        • Pharmacognosy and Phytochemistry – I
          • Unit 1
          • Unit 2
          • Unit 3
          • Unit 4
          • Unit 5
      • SEM-V
        • Medicinal Chemistry II
          • mc2 Unit 1
        • Industrial Pharmacy I
          • Unit 1
          • Unit 2
          • BIP Unit 3
          • BIP Unit 4
        • Pharmacology-II
          • Unit 1
          • Unit 2
          • colo2 Unit 3
        • Pharmacognosy & Phytochemistry II
          • Unit 1
          • Unit 2
          • cog Unit 3
        • Pharmaceutical Jurisprudence
          • Unit 1
          • Unit 2
          • Unit 3
          • juris Unit 4
      • SEM-VI
        • Medicinal Chemistry III
          • MC III Unit 1
        • Herbal Drug Technology
          • Unit 1
          • HDT Unit 2
        • Biopharmaceutics & Pharmacokinetics
          • kinet Unit 1
          • Kinet Unit 2
        • Pharmaceutical Biotechnology
          • Unit 1
          • Unit 2
          • biotech Unit 3
        • Pharmaceutical Quality Assurance
          • Unit 1
      • SEM- VII
        • Instrumental Method of Analysis
          • lysis Unit 1
          • Unit 3
          • Unit 4
          • Unit 5
        • Industrial Pharmacy-II
          • IP 2 Unit 1
        • Pharmacy Practice
          • Unit 1
          • pp Unit 2
        • Novel Drug Delivery System
          • Unit 1
          • ndds Unit 2
      • SEM-VIII
        • Biostatistics and Research Methodology
          • Unit 1
        • Pharmacovigilance
          • Unit-1
          • Unit 2
          • Unit 3
          • vigi Unit 4
        • Social and Preventive Pharmacy
          • Social Unit 1
    • B.Pharm New PCI Syllabus 2026
      • SEM-1 new
        • Basics of Python Programming for Pharmaceutical Sciences
          • Unit 1
          • Python Unit 2
        • General Pharmacy
          • Unit 1
          • Unit 2
          • Unit 3
        • Healthcare Psychology and Communication Skills
          • Unit 1
          • HPCS Unit 2
        • Human Anatomy, Physiology and Pathophysiology I
          • Unit 1
          • New HAP Unit 2
        • Introduction to Pharmacognosy
          • Unit 1
        • Pharmaceutical Inorganic and Analytical Chemistry
          • Unit 1
          • Unit 2
          • new ana Unit 3
    • D.Pharma
      • Pharmaceutics
        • Chapter 1
        • Chapter 2
        • Chpater 3
        • Chpater 4
        • dceu Chapter 5
      • Pharmaceutical Chemistry
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • dchem Chapter 6
      • Pharmacognosy
        • Chapter 3
        • Chapter 1
        • Chapter 2
        • Chapter 4
        • cogno Chapter 5
      • Human Anatomy and Physiology
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • Chapter 6
        • Chapter 7
        • Chapter 8
        • Chapter 9
        • Chapter 10
        • Chapter 11
        • Chapter 12
        • Chapter 13
        • Chapter 14
        • Chapter 15
      • Social Pharmacy
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • sp Chapter 4
      • Pharmacology
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • Chapter 6
        • Chapter 7
        • Chapter 8
        • Chapter 9
        • Chapter 10
        • Chapter 11
        • Chapter 12
        • Chapter 13
      • Community pharmacy and management
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 5
        • Chapter 6
        • Chapter 7
        • cpm Chapter 8
      • Biochemistry & Clinical Pathology
        • Chapter 1
        • Chapter 2
        • Chapter 3
        • Chapter 4
        • Chapter 5
        • Chapter 6
        • Chapter 7
      • Pharmacotherapeutics
        • Chapter 1
        • the Chapter 2
      • Hospital and Clinical Pharmacy
        • Chapter 1
        • Chapter 2
        • hcp Chapter 3
      • Pharmacy law and Ethics
        • Chapter 1
        • Chapter 2
    • M.Pharm
      • Pharmacology Branch
    • Pharm D
      • Human Anatomy & Physiology (D)
        • Unit 1
        • Unit 2
        • Unit 3
        • hap Unit 4 (D)
        • Unit 5
        • Unit 6
        • Unit 7
        • Unit 8
        • Unit 9
        • Unit 10
        • Unit 11
        • Unit 12
        • hap Unit 13
    • DMLT
      • dmlt 1 year
        • Anatomy and Physiology
  • Study Material
    • Practicals
    • Notes pdf
    • Previous year papers
    • Books
  • Blog
  • Jobs
  • Syllabus
Search